190 related articles for article (PubMed ID: 31004030)
1. Flow cytometric analysis of neutrophil myeloperoxidase expression in peripheral blood for ruling out myelodysplastic syndromes: a diagnostic accuracy study.
Raskovalova T; Berger MG; Jacob MC; Park S; Campos L; Aanei CM; Kasprzak J; Pereira B; Labarère J; Cesbron JY; Veyrat-Masson R
Haematologica; 2019 Dec; 104(12):2382-2390. PubMed ID: 31004030
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression for ruling out myelodysplastic syndromes: a prospective validation study.
Raskovalova T; Jacob MC; Bulabois CE; Mariette C; Scheffen L; Park S; Labarère J
Ann Hematol; 2021 May; 100(5):1149-1158. PubMed ID: 33569703
[TBL] [Abstract][Full Text] [Related]
3. Comparative diagnostic accuracy between simplified and original flow cytometric gating strategies for peripheral blood neutrophil myeloperoxidase expression in ruling out myelodysplastic syndromes.
Raskovalova T; Scheffen L; Jacob MC; Vettier C; Bulabois B; Szymanski G; Chevalier S; Gonnet N; Park S; Labarère J
PLoS One; 2022; 17(11):e0276095. PubMed ID: 36399441
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometry lyophilised-reagent tube for quantifying peripheral blood neutrophil myeloperoxidase expression in myelodysplastic syndromes (MPO-MDS-Develop): protocol for a diagnostic accuracy study.
Raskovalova T; Scheffen L; Jacob MC; Chevalier S; Tondeur S; Bulabois B; Meunier M; Szymanski G; Lefebvre C; Planta C; Dumestre-Perard C; Gonnet N; Garban F; Merle R; Park S; Labarère J
BMJ Open; 2022 Oct; 12(10):e065850. PubMed ID: 36207039
[TBL] [Abstract][Full Text] [Related]
5. Utility of peripheral blood flow cytometry in differentiating low grade versus high grade myelodysplastic syndromes (MDS) and in the evaluation of cytopenias.
Rashidi HH; Xu X; Wang HY; Shafi NQ; Rameshkumar K; Messer K; Smith BR; Rose MG
Int J Clin Exp Pathol; 2012; 5(3):224-30. PubMed ID: 22558477
[TBL] [Abstract][Full Text] [Related]
6. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.
Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
Cytometry B Clin Cytom; 2005 Mar; 64(1):9-17. PubMed ID: 15668954
[TBL] [Abstract][Full Text] [Related]
7. [Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia].
Wang YX; Zhang JH; Hu YP; Cao FF; Zhang N; Chen F; Liu X; Zhang MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):857-62. PubMed ID: 22931642
[TBL] [Abstract][Full Text] [Related]
8. Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group.
Kern W; Westers TM; Bellos F; Bene MC; Bettelheim P; Brodersen LE; Burbury K; Chu SC; Cullen M; Porta MD; Dunlop AS; Johansson U; Matarraz S; Oelschlaegel U; Ogata K; Porwit A; Preijers F; Psarra K; Saft L; Subirá D; Weiß E; van der Velden VHJ; van de Loosdrecht A
Cytometry B Clin Cytom; 2023 Jan; 104(1):51-65. PubMed ID: 36416672
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes.
Mathis S; Chapuis N; Debord C; Rouquette A; Radford-Weiss I; Park S; Dreyfus F; Lacombe C; Béné MC; Kosmider O; Fontenay M; Bardet V
Leukemia; 2013 Oct; 27(10):1981-7. PubMed ID: 23765225
[TBL] [Abstract][Full Text] [Related]
10. PDE4 Differential Expression Is a Potential Prognostic Factor and Therapeutic Target in Patients With Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia.
Chamseddine AN; Cabrero M; Wei Y; Ganan-Gomez I; Colla S; Takahashi K; Yang H; Bohannan ZS; Garcia-Manero G
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S67-73. PubMed ID: 27521329
[TBL] [Abstract][Full Text] [Related]
11. Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations.
Alhan C; Westers TM; Cremers EM; Cali C; Ossenkoppele GJ; van de Loosdrecht AA
Cytometry B Clin Cytom; 2016 Jul; 90(4):358-67. PubMed ID: 26517178
[TBL] [Abstract][Full Text] [Related]
12. Distinct neutrophil subpopulations phenotype by flow cytometry in myelodysplastic syndromes.
Vikentiou M; Psarra K; Kapsimali V; Liapis K; Michael M; Tsionos K; Lianidou E; Papasteriades C
Leuk Lymphoma; 2009 Mar; 50(3):401-9. PubMed ID: 19294559
[TBL] [Abstract][Full Text] [Related]
13. The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML).
Hasle H; Baumann I; Bergsträsser E; Fenu S; Fischer A; Kardos G; Kerndrup G; Locatelli F; Rogge T; Schultz KR; Starý J; Trebo M; van den Heuvel-Eibrink MM; Harbott J; Nöllke P; Niemeyer CM;
Leukemia; 2004 Dec; 18(12):2008-14. PubMed ID: 15496981
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of flow cytometric assessment of myeloid nuclear differentiation antigen expression as a diagnostic marker for myelodysplastic syndromes in a series of 269 patients.
Bellos F; Alpermann T; Gouberman E; Haferlach C; Schnittger S; Haferlach T; Kern W
Cytometry B Clin Cytom; 2012 Sep; 82(5):295-304. PubMed ID: 22508616
[TBL] [Abstract][Full Text] [Related]
15. The effects of GM-CSF on myeloperoxidase release in normal and myelodysplastic neutrophils.
Dang Y; Lowe GM; Edwards SW; Galvani DW
Leuk Res; 1993 Dec; 17(12):1037-44. PubMed ID: 8246607
[TBL] [Abstract][Full Text] [Related]
16. Erythroid side scatter: A parameter that improves diagnostic accuracy of flow cytometry myelodysplastic syndrome scoring.
Johansson U; Rolf N; Futhee N; Stewart A
Cytometry B Clin Cytom; 2023 Mar; 104(2):151-161. PubMed ID: 35388621
[TBL] [Abstract][Full Text] [Related]
17. Flow-cytometric analysis of peripheral blood neutrophils: a simple, objective, independent and potentially clinically useful assay to facilitate the diagnosis of myelodysplastic syndromes.
Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
Am J Hematol; 2005 Jul; 79(3):243-5. PubMed ID: 15981222
[TBL] [Abstract][Full Text] [Related]
18. Value of Quantitative assessment of Myeloid Nuclear Differentiation Antigen expression and other flow cytometric parameters in the diagnosis of Myelodysplastic syndrome.
Somasundaram V; Soni S; Chopra A; Rai S; Mahapatra M; Kumar R; Pati H
Int J Lab Hematol; 2016 Apr; 38(2):141-50. PubMed ID: 26822549
[TBL] [Abstract][Full Text] [Related]
19. A single-tube flow cytometric procedure for enhancing the diagnosis and prognostic classification of patients with myelodysplastic syndromes.
Kárai B; Bedekovics J; Miltényi Z; Gergely L; Szerafin L; Ujfalusi A; Kappelmayer J; Hevessy Z
Int J Lab Hematol; 2017 Dec; 39(6):577-584. PubMed ID: 28625017
[TBL] [Abstract][Full Text] [Related]
20. Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias.
Cremers EMP; Westers TM; Alhan C; Cali C; Wondergem MJ; Poddighe PJ; Ossenkoppele GJ; van de Loosdrecht AA
Eur J Cancer; 2016 Feb; 54():49-56. PubMed ID: 26720403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
